✦ LIBER ✦

Cost analysis of secondary prophylaxis with oral clodronate versus pamidronate in metastatic breast cancer patients

✍ Scribed by Dorothy Romanus; Neill Iscoe; Carlo DeAngelis; Neil Shear; Thomas R. Einarson

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cost-Effectiveness of Primary versus Sec

✍ Scott D. Ramsey; Zhimei Liu; Rob Boer; Sean D. Sullivan; Jennifer Malin; Quan V. 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 205 KB

Cost-effectiveness of oral ibandronate c

✍ E. Cock; J. Hutton; P. Canney; J. J. Body; P. Barrett-Lee; M. P. Neary; G. Lewis 📂 Article 📅 2005 🏛 Springer-Verlag 🌐 English ⚖ 200 KB

Cost utility analysis of prophylactic pa

✍ G. Dranitsaris; Tom Hsu 📂 Article 📅 1999 🏛 Springer-Verlag 🌐 English ⚖ 73 KB

Cost-effectiveness analyses of docetaxel

✍ Carmen Frías; Javier Cortés; Miguel Ángel Seguí; Itziar Oyagüez; Miguel Ángel Ca 📂 Article 📅 2010 🏛 Springer Milan 🌐 Spanish ⚖ 389 KB